ASGE Member Letter
“Medicine’s most successful efforts against cancer have resulted from the detection of precancerous lesions that harbor dysplasia, followed by their endoscopic treatment (resection or ablation) or surgical removal. This preemption strategy enabled screening colonoscopy to make sporadic colon cancer a potentially preventable disease, and it took cervical cancer from the largest cause of female cancer death in the 1950s to the 14th largest by the 1970s.
Until recently, two factors have impaired our ability to apply this preemption strategy to esophageal adenocarcinoma: reliable de tection of dysplastic Barrett’s and effective treatment for dysplastic mucosa that is safe and widely available.
That paradigm has changed…”
ASGE Tech Talks Video
“The Role of Wide-Area Transepithelial Sampling (WATS) Procedure in the Screening for and Surveillance of Barrett’s Esophagus”
Click to watch the video of Drs. Seth Gross and Prateek Sharma discussing how WATS can sample a wider area and provide additional information through all the cells collected in the brush.
© 2018 American Society for Gastrointestinal Endoscopy